The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The obvious answer is pay, and there’s some credence to that explanation. Between 2012 and 2022, pay adjusted for inflation ...

A pharmacist has once-again gone viral on TikTok after revealing which popular over-the-counter medicine you should avoid ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.